Apoptotic pathways involved in U937 cells exposed to LDL oxidized by hypochlorous acid

Free Radical Biology and Medicine

Volumn 35, Issue 6, 2003, Pages 603-615

  Vicca, Stéphanie ^a   Massy, Ziad A ^a,b   Hennequin, Carole ^a   Rihane, Djamel ^a   Drüeke, Tilman B ^a   Lacour, Bernard ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ DE PICARDIE JULES VERNE   (France)

Author keywords

Apoptosis; Atherogenesis; Caspases; Free radicals; HOCl oxidized LDL

Indexed keywords

CASPASE 2; CASPASE 3; CASPASE 8; CASPASE 9; FAS ANTIBODY; HYPOCHLOROUS ACID; LOW DENSITY LIPOPROTEIN; PROTEIN BCL 2; RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR 1;

APOPTOSIS; ARTICLE; ATHEROGENESIS; CELL STRAIN U937; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MOLECULAR CLONING; MONOCYTE; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0041827347     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(03)00361-7     Document Type: Article

References (50)

1. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature. 362:1993;801-809.
2. Yla-Herttuala S., Palinski W., Rosenfeld M.E., Parthasarathy S., Carew T.E., Butler S., Witztum J.L., Steinberg D. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J. Clin. Invest. 84:1989;1086-1095.
3. Leeuwenburgh C., Rasmussen J.E., Hsu F.F., Mueller D.M., Pennathur S., Heinecke J.W. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques. J. Biol. Chem. 272:1997;3520-3526.
4. Hazell L.J., Stocker R. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages. Biochem. J. 290:1993;165-172.
5. Hazell L.J., Van Den Berg J.J.M., Stocker R. Oxidation of low-density lipoprotein by hypochlorite causes aggregation that is mediated by modification of lysine residues rather than lipid oxidation. Biochem. J. 302:1994;297-304.
6. Heinecke J.W. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr. Opin. Lipidol. 8:1997;268-274.
7. Daugherty A., Dunn J.L., Rateri D.L., Heinecke J.W. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:1994;437-444.
8. Hazell L.J., Arnold L., Flowers D., Waeg G., Malle E., Stocker R. Presence of hypochlorite-modified proteins in human atherosclerotic lesions. J. Clin. Invest. 97:1996;1535-1544.
9. Malle E., Woenckhaus C., Waeg G., Esterbauer H., Gröne E.F., Gröne H.J. Immunological evidence for hypochlorite-modified proteins in human kidney. Am. J. Pathol. 150:1997;603-615.
10. Nguyen-Khoa T., Massy Z.A., Witko-Sarsat V., Canteloup S., Kebede M., Lacour B., Drüeke T.B., Descamps-Latscha B. Oxidized low-density lipoprotein induces macrophage respiratory burst via its protein moiety a novel pathway in atherogenesis? Biochem. Biophys. Res. Commun. 263:1999;804-809.
11. 2+-ATPase activity of human platelets. Cell Calcium. 26:1999;281-287.
12. Bjorkerud S., Bjorkerud B. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am. J. Pathol. 149:1996;367-380.
13. Bjorkerud B., Bjorkerud S. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts. Arterioscler. Thromb. Vasc. Biol. 16:1996;416-424.
14. Escargueil-Blanc I., Meilhac O., Pieraggi M.-T., Arnal J.-F., Salvayre R., Nègre-Salvayre A. Oxidized LDLs induce massive apoptosis of cultured human endothelial cells through a calcium-dependent pathway. Arterioscler. Thromb. Vasc. Biol. 17:1996;331-339.
15. Harada-Shiba M., Kinoshita M., Kamido H., Shimokado K. Oxidized low density lipoprotein induces apoptosis in cultured human umbilical vein endothelial cells by common and unique mechanisms. J. Biol. Chem. 273:1998;9681-9687.
16. Farber A., Kitzmiller T., Morganelli P.M., Pfeiffer J., Groveman D., Wagner R.J., Cronenwett J.L., Powell R.J. A caspase inhibitor decreases oxidized low-density lipoprotein-induced apoptosis in bovine endothelial cells. J. Surg. Res. 85:1999;323-330.
17. Hardwick S.J., Hegyi L., Clare K., Law N.S., Carpenter K.L.H., Mitchinson M.J., Skepper J.N. Apoptosis in human monocyte-macrophages exposed to oxidized low density lipoprotein. J. Pathol. 179:1996;294-302.
18. Crisby M., Kallin B., Thyberg J., Zhivotovsky B., Orrenius S., Kostulas V., Nilsson J. Cell death in human atherosclerotic plaques involves both oncosis and apoptosis. Atherosclerosis. 130:1997;17-27.
19. Vicca S., Hennequin C., Nguyen-Khoa T., Massy Z.A., Descamps-Latscha B., Drüeke T.B., Lacour B. Caspase-dependent apoptosis in THP-1 cells exposed to oxidized-low density lipoproteins. Biochem. Biophys. Res. Commun. 273:2000;948-954.
20. Green D.R. Apoptotic pathways the roads to ruin . Cell. 94:1998;695-698.
21. Renvoizé C., Roger R., Moulian N., Bertoglio J., Bréard J. Bcl-2 expression in target cells leads to functional inhibition of caspase-3 protease family in human NK and lymphokine-activated killer cell granule-mediated apoptosis. J. Immunol. 159:1997;126-134.
22. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 24:1955;1345-1353.
23. Conti M., Morand P.C., Levillain P., Lemonnier A. Improved fluorometric determination of malonaldehyde. Clin. Chem. 37:1991;1273-1275.
24. Witko-Sarsat V., Friedlander M., Capeillère-Blandin C., Nguyen-Khoa T., Nguyen A.T., Zingraff J., Jungers P., Descamps-Latscha B. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49:1996;1304-1313.
25. 2-glycoprotein I). Life Sci. 69:2001;707-719.
26. Wang T.T.Y., Phang J.M. Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. Cancer Res. 55:1995;2487-2489.
27. Nicoletti I., Migliorati G., Pagliaci M.C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139:1991;271-280.
28. Koopman G., Reutelingsperger C.P., Kuijten G.A., Keehnen R.M., Pals S.T., van Oers M.H. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood. 84:1994;1415-1420.
29. Chen L.B. Mitochondrial membrane potential in living cells. Annu. Rev. Cell Biol. 4:1988;155-181.
30. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis. Free Radic. Biol. Med. 20:1996;707-727.
31. Napoli C. Low density lipoprotein oxidation and variant angina role of methodologic procedures in assessment of oxidizability of low density lipoprotein . J. Am. Coll. Cardiol. 28:1996;1637-1638.
32. Hazen S.L., Hsu F.F., Duffin K., Heinecke J.W. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. J. Biol. Chem. 271:1996;23080-23088.
33. Anderson M.M., Hazen S.L., Hsu F.F., Heinecke J.W. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. J. Clin. Invest. 99:1997;424-432.
34. Marsche G., Hammer A., Oskolkova O., Kozarsky K.F., Sattler W., Malle E. Hypochlorite-modified high density lipoprotein, a high affinity ligand to scavenger receptor class B, type I impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport. J. Biol. Chem. 277:2002;32172-32179.
35. Drüeke T., Witko-Sarsat V., Massy Z., Descamps-Latscha B., Guerin A.P., Marchais S.J., Gausson V., London G.M. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation. 106:2002;2212-2217.
36. Mallat Z., Tedgui A. Current perspective on the role of apoptosis in atherothrombotic disease. Circ. Res. 88:2001;998-1003.
37. Napoli C., Quehenberger O., deNigris F., Abete P., Glass C.K., Palinski W. Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells. FASEB J. 14:2000;1996-2007.
38. Wintergerst E.S., Jelk J., Rahner C., Asmis R. Apoptosis induced by oxidized low density lipoprotein in human monocyte-derived macrophages involves CD36 and activation of caspase-3. Eur. J. Biochem. 267:2000;6050-6058.
39. Fantuzzi G., Puren A.J., Harding M.W., Livingston D.J., Dinarello C.A. Interleukin-18 regulation of interferonγ production and cell proliferation as shown in interleukin-1β-converting enzyme (caspase-1)-deficient mice. Blood. 91:1998;2118-2125.
40. Scaffidi C., Fulda S., Srinivasan A., Friesen C., Li F., Tomaselli K.J., Debatin K.M., Krammer P.H., Peter M.E. Two CD95 (APO-1/Fas) signaling pathways. EMBO J. 17:1998;1675-1687.
41. Sordet O., Rébé C., Plenchette S., Zermati Y., Hermine O., Vainchenker W., Garrido C., Solary E., Dubrez-Daloz L. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood. 100:2002;4446-4453.
42. Lee T.S., Chau L.Y. Fas/Fas ligand-mediated death pathway is involved in oxLDL-induced apoptosis in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 280:2001;C709-C718.
43. Asmis R., Begley J.G. Oxidized LDL promotes peroxide-mediated mitochondrial dysfunction and cell death in human macrophages a caspase-3-independent pathway . Circ. Res. 92:2003;20e-29e.
44. Chae Y.J., Kim H.S., Rhim H., Kim B.E., Jeong S.W., Kim I.K. Activation of caspase-8 in 3-deazaadenosine-induced apoptosis of U-937 cells occurs downstream of caspase-3 and caspase-9 without Fas receptor-ligand interaction. Exp. Mol. Med. 33:2001;284-292.
45. Micheau O., Solary E., Hammann A., Dimanche-Boitrel M.T. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J. Biol. Chem. 274:1999;7987-7992.
46. Sordet O., Bettaieb A., Bruey J.M., Eymin B., Droin N., Ivarsson M., Garrido C., Solary E. Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells. Cell Death Differ. 6:1999;351-361.
47. Kubo N., Kikuchi J., Furukawa Y., Sakai T., Ohta H., Iwase S., Yamada H., Sakurabayashi I. Regulatory effects of aggregated LDL on apoptosis during foam cell formation of human peripheral blood monocytes. FEBS Lett. 409:1997;177-182. Hundal R.S., Salh B.S., Schrader J.W., Gomez-Munoz A., Duronio V., Steinbrecher U.P. Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway. J. Lipid Res. 42:2001;1483-1491.
48. Hundal R.S., Salh B.S., Schrader J.W., Gomez-Munoz A., Duronio V., Steinbrecher U.P. Oxidized low density lipoprotein inhibits macrophage apoptosis through activation of the PI 3-kinase/PKB pathway. J. Lipid Res. 42:2001;1483-1491.
49. Hida A., Kawakami A., Nakashima T., Yamasaki S., Sakai H., Urayama S., Ida H., Nakamura H., Migita K., Kawabe Y., Eguchi K. Nuclear factor-κB and caspases co-operatively regulate the activation and apoptosis of human macrophages. Immunology. 99:2000;553-560.
50. Sugiyama S., Okada Y., Sukhova G.K., Virmani R., Heinecke J.W., Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am. J. Pathol. 158:2001;879-891.